Speaker:

John Bartlett, MD  Professor Emeritus, Johns Hopkins University School of Medicine, Belden, Mississippi. He served as Chief of the Infectious Diseases Division at Johns Hopkins for 26 years before stepping down in June of 2006.  Past President of the Infectious Disease Society of America.

Objectives: 

• The crisis of antibiotic resistance and the ambitious CDC/CMS response to respond that will impact virtually all physicians who prescribe antibiotics
• Molecular microbiologyu developments that are likely to dramatically change laboratory testing and pathogen tracing.
• Important changes have recently been made in concepts about community-acquired pheumonia, C. difficile infection, hepatitis C management, six new antibiotics and three vaccine strategies.

Innovation Minute:

Steven Lester, MD  

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Yuma Regional Medical Center
• Canyon Ranch Medical Center
• Mayo Clinic Primary Care – San Tan

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

**NEW** ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.  

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.